Sepsis leads to life-threatening organ failure due to dysregulated host responses to infection and presents uniquely across age groups. Neonatal sepsis, affecting infants in their first 28 days, ...

HAMILTON, ON (November 25, 2021) – Each year, sepsis affects more than 30 million people worldwide, causing an estimated six million deaths. Sepsis is the body’s extreme response to an infection and ...

A major multi-country study has found that WHO-recommended first-line antibiotics for neonatal sepsis are likely to be effective in only one-quarter of infections in low- and middle-income countries ...

Background Users often regard the 2022 WHO verbal autopsy (VA) instrument as lengthy and time-consuming to implement, ...

Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

Striking at the heart of antimicrobial resistance, the international NeoSep 1 trial to evaluate life-saving antibiotic combinations for newborns with sepsis has expanded to India, with the first baby ...

LISBON, Portugal — A shift toward broader-spectrum antibiotics and increasing antibiotic resistance has led to high levels of mortality and neurodevelopmental impacts in surviving babies, according to ...

Each year, sepsis affects more than 30 million people worldwide, causing an estimated six million deaths. Sepsis is the body's extreme response to an infection and is often life-threatening. Since ...